Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01593475
What this trial is testing

Induction Chemotherapy With Gemcitabine and Cisplatin Followed by CCRT for Unresectable Pancreatic Carcinoma

Who this might be right for
Pancreatic Carcinoma Non-resectable
National Cancer Center, Korea 44
Testing effectiveness (Phase 2)Looking for participantsNCT06690775
What this trial is testing

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Who this might be right for
Epithelial Ovarian CancerPrimary PeritonealFallopian Tube Cancer+1 more
TORL Biotherapeutics, LLC 230
Not applicableUnknownNCT06416319
What this trial is testing

Preoperative Physical Activity Improvement With the Use of Activity Trackers Before Radical Cystectomy (PreAct)

Who this might be right for
Bladder CancerBladder NeoplasmBladder Urothelial Carcinoma
Universitätsmedizin Mannheim 164
Testing effectiveness (Phase 2)Looking for participantsNCT07457528
What this trial is testing

Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC

Who this might be right for
Resectable Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 46
Testing effectiveness (Phase 2)Looking for participantsNCT07223307
What this trial is testing

REGULUS: MRI-guided Adaptive SABR for Liver Cancers

Who this might be right for
Liver CancerIntrahepatic CholangiocarcinomaLiver Metastases+1 more
Stanford University 62
Not applicableNot Yet RecruitingNCT04053231
What this trial is testing

Hepatocarcinoma Recurrence on the Liver Study - Part2

Who this might be right for
Liver CancerSurgeryRecurrence Tumor+1 more
University of Milano Bicocca 3,000
Testing effectiveness (Phase 2)UnknownNCT03219775
What this trial is testing

Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma

Who this might be right for
Transitional Cell CarcinomaAdvanced CancerMetastatic Cancer
AIO-Studien-gGmbH 169
Very early researchStudy completedNCT03647657
What this trial is testing

177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer

Who this might be right for
Thyroid Cancer, Medullary
University Hospital, Basel, Switzerland 8
Testing effectiveness (Phase 2)Study completedNCT01533181
What this trial is testing

Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Recurrent Small Cell Lung Carcinoma
National Cancer Institute (NCI) 44
Not applicableLooking for participantsNCT07508319
What this trial is testing

Role of the Immune System in Preventing Laryngeal Cancer

Who this might be right for
Head & Neck Cancer
European Institute of Oncology 3
Early research (Phase 1)Ended earlyNCT02687230
What this trial is testing

Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1

Who this might be right for
Pancreatic CarcinomaTumors That Express CA19-9
BioNTech Research & Development, Inc. 15
Testing effectiveness (Phase 2)Looking for participantsNCT05498428
What this trial is testing

Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-small-Cell Lung
Janssen Research & Development, LLC 520
Large-scale testing (Phase 3)Active Not RecruitingNCT04214067
What this trial is testing

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer

Who this might be right for
Endometrial Endometrioid AdenocarcinomaStage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8Stage II Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
National Cancer Institute (NCI) 164
Testing effectiveness (Phase 2)Looking for participantsNCT07497607
What this trial is testing

Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oropharyngeal Squamous Cell CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma
Sara Medek 31
Testing effectiveness (Phase 2)Looking for participantsNCT06607692
What this trial is testing

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

Who this might be right for
Solid Tumor CancerMedulloblastomaHigh Risk Neuroblastoma+19 more
Fundación de investigación HM 25
Testing effectiveness (Phase 2)Study completedNCT00006471
What this trial is testing

Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Ended earlyNCT02335944
What this trial is testing

Study of Safety and Efficacy of EGFR-TKI EGF816 in Combination With cMET Inhibitor INC280 in Adult Patients With EGFR Mutated Non Small Cell Lung Cancer.

Who this might be right for
Non Small Cell Lung Cancer
Novartis Pharmaceuticals 177
Not applicableEnded earlyNCT06069453
What this trial is testing

Hyaluronic Acid Sodium Salt and Hydeal-D in the Management of LUTS After TURBT for NMIBC.

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Fidia Farmaceutici s.p.a. 54
Large-scale testing (Phase 3)Study completedNCT01631357
What this trial is testing

Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer

Who this might be right for
Non-small Cell Lung CancerSquamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 96
Not applicableUnknownNCT04553601
What this trial is testing

Molecular Imaging Visualization of Tumor Heterogeneity in Non-small Cell Lung Cancer

Who this might be right for
NSCLCPET/CTBiopsy+3 more
The First Affiliated Hospital of Xiamen University 150
Next Page